ARCHIVES

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

This article is from The Cancer Letter archive.

Vol. 32 No. 29 | July 28, 2006

Download PDF Visit The Full Archive

Related Articles

NTP Board Gives Concept Approvals

December 4, 1981

Rep. Bliley Challenges FDA On Failure To Approve Oral Colon Cancer Drug UFT.

April 21, 2000

AACR Elects Officers.

April 9, 2010

NCI Director Broder, Going On 3rd Year, Examines Issues Of Funding, Priorities, For Institute’s Future

September 20, 1991

NIH Guidelines Define Eligible Research Using Stem Cells.

September 8, 2000

Carbone Names NCI Clinical Director, Rauscher shuffles Treatment Activities

August 30, 1974